The study of genomic alterations in primary melanomas showed that tumors with B-RAF mutations had few copies of PTEN, suggesting that dual activation of the PI3K-AKT and MAPK pathways are important events in melanoma development (73). This evidence concerns the gene AKT1 and melanoma.